Mata Nathan L.'s Form 4 filing
Belite Bio, Inc (BLTE) · filed Apr 22, 2026
- Accession no.
- 0001193125-26-170443
- Filed
- Apr 22, 2026
- Trade date
- Apr 21, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions. Open-market sales total $166.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mata Nathan L.CIK 0002013987 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | American depositary share | SSaleDisposed | −64 | $163.49F3 | −$10,463.36 | 12,602 | Direct | |
| Apr 21, 2026 | American depositary share | SSaleDisposed | −78 | $164.60F4 | −$12,838.8 | 12,524 | Direct | |
| Apr 21, 2026 | American depositary share | SSaleDisposed | −332 | $165.49F5 | −$54,942.68 | 12,192 | Direct | |
| Apr 21, 2026 | American depositary share | SSaleDisposed | −312 | $166.49F6 | −$51,944.88 | 11,880 | Direct | |
| Apr 21, 2026 | American depositary share | SSaleDisposed | −214 | $167.34F7 | −$35,810.76 | 11,666 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average price of shares sold at prices that ranged from $163.26 to $163.88. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of shares sold at prices that ranged from $164.11 to $164.93. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average price of shares sold at prices that ranged from $165.09 to $165.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average price of shares sold at prices that ranged from $166.07 to $166.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents the weighted average price of shares sold at prices that ranged from $167.01 to $167.94. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.